Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S., Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell’Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier
Published in International journal of hematology (01.02.2022)
Published in International journal of hematology (01.02.2022)
Get full text
Journal Article
Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial
Casulo, Carla, Santoro, Armando, Cartron, Guillaume, Ando, Kiyoshi, Munoz, Javier, Le Gouill, Steven, Izutsu, Koji, Rule, Simon, Lugtenburg, Pieternella, Ruan, Jia, Arcaini, Luca, Casadebaig, Marie‐Laure, Fox, Brian, Kilavuz, Nurgul, Rettby, Nils, Dell'Aringa, Justine, Taningco, Lilia, Delarue, Richard, Czuczman, Myron, Witzig, Thomas
Published in Cancer reports (01.01.2023)
Published in Cancer reports (01.01.2023)
Get full text
Journal Article
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
Thieblemont, Catherine, Phillips, Tycel, Ghesquieres, Herve, Cheah, Chan Y, Clausen, Michael Roost, Cunningham, David, Do, Young Rok, Feldman, Tatyana, Gasiorowski, Robin, Jurczak, Wojciech, Kim, Tae Min, Lewis, David John, van der Poel, Marjolein, Poon, Michelle Limei, Cota Stirner, Mariana, Kilavuz, Nurgul, Chiu, Christopher, Chen, Menghui, Sacchi, Mariana, Elliott, Brian, Ahmadi, Tahamtan, Hutchings, Martin, Lugtenburg, Pieternella J
Published in Journal of clinical oncology (20.04.2023)
Published in Journal of clinical oncology (20.04.2023)
Get full text
Journal Article
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies
Ogasawara, Ken, Newhall, Kathryn, Maxwell, Stephen E., Dell’Aringa, Justine, Komashko, Vitalina, Kilavuz, Nurgul, Delarue, Richard, Czuczman, Myron, Sternas, Lars, Rose, Shelonitda, Beach, C. L., Novick, Steven, Zhou, Simon, Palmisano, Maria, Li, Yan
Published in Clinical pharmacokinetics (01.02.2020)
Published in Clinical pharmacokinetics (01.02.2020)
Get full text
Journal Article
Mitigating the Risk of Cytokine Release Syndrome (CRS): Preliminary Results from a DLBCL Cohort of Epcore NHL-1
Vose, Julie M., Feldman, Tatyana, Chamuleau, Martine E.D., Kim, Won Seog, Lugtenburg, Pieternella, Kim, Tae Min, Costa, Pau Abrisqueta, Cheah, Chan Y., Glimelius, Ingrid Cecilia, Hess, Brian, Jurczak, Wojciech, Musuraca, Gerardo, Olszewski, Adam J., Dinh, Minh, Kilavuz, Nurgul, Wielgos-Bonvallet, Monica, Li, Tommy, Li, Zhu, Eskelund, Christian, Farooq, Umar
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Improvements in Patient-Reported Outcomes in Relapsed or Refractory Large B-Cell Lymphoma Patients Treated With Epcoritamab
Phillips, Tycel, Lugtenburg, Pieternella, Kalsekar, Anupama, Mutebi, Alex, Wang, Anthony, Blaedel, Julie, Kosa, Katherine, Martin, Susan, Sacchi, Mariana, Kilavuz, Nurgul, Thieblemont, Catherine
Published in Clinical lymphoma, myeloma and leukemia (01.03.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.03.2024)
Get full text
Journal Article
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Thieblemont, Catherine, Karimi, Yasmin H, Ghesquieres, Herve, Cheah, Chan Y, Clausen, Michael Roost, Cunningham, David, Jurczak, Wojciech, Do, Young Rok, Gasiorowski, Robin, Lewis, David John, Kim, Tae Min, van der Poel, Marjolein, Poon, Michelle Limei, Feldman, Tatyana, Linton, Kim M, Sureda, Anna, Hutchings, Martin, Dinh, Minh H, Kilavuz, Nurgul, Soong, David, Mark, Thomas, Sacchi, Mariana, Phillips, Tycel, Lugtenburg, Pieternella J
Published in Leukemia (25.09.2024)
Published in Leukemia (25.09.2024)
Get full text
Journal Article
Epcoritamab Monotherapy Provides Deep and Durable Responses Including Minimal Residual Disease (MRD) Negativity: Novel Subgroup Analyses in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Phillips, Tycel, Thieblemont, Catherine, Ghesquieres, Herve, Cheah, Chan Y., Clausen, Michael Roost, Cunningham, David, Do, Young Rok, Feldman, Tatyana A., Gasiorowski, Robin, Jurczak, Wojciech, Kim, Tae Min, Lewis, David John, van der Poel, Marjolein, Poon, Michelle Limei, Kilavuz, Nurgul, Cota Stirner, Mariana, Soong, David, Chiu, Christopher, Chen, Menghui, Sacchi, Mariana, Elliot, Brian, Hutchings, Martin, Lugtenburg, Pieternella
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
POSTER: ABCL-500 Longer Follow-Up Reaffirms Subcutaneous Epcoritamab Induces Deep and Durable Complete Remissions in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Updated Results From the Pivotal EPCORE NHL-1 Trial
Karimi, Yasmin, Ghesquieres, Herve, Jurczak, Wojciech, Cheah, Chan Y., Clausen, Michael Roost, Lugtenburg, Pieternella, Cunningham, David, Do, Young Rok, Lewis, David John, Gasiorowski, Robin, Kim, Tae Min, van der Poel, Marjolein, Poon, Michelle Limei, Feldman, Tatyana, Linton, Kim M., Sureda, Anna, Hutchings, Martin, Stirner, Mariana Cota, Liu, Yan, Kilavuz, Nurgul, Sacchi, Mariana, Thieblemont, Catherine
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
ABCL-500 Longer Follow-Up Reaffirms Subcutaneous Epcoritamab Induces Deep and Durable Complete Remissions in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Updated Results From the Pivotal EPCORE NHL-1 Trial
Karimi, Yasmin, Ghesquieres, Herve, Jurczak, Wojciech, Cheah, Chan Y., Clausen, Michael Roost, Lugtenburg, Pieternella, Cunningham, David, Do, Young Rok, Lewis, David John, Gasiorowski, Robin, Kim, Tae Min, van der Poel, Marjolein, Poon, Michelle Limei, Feldman, Tatyana, Linton, Kim M., Sureda, Anna, Hutchings, Martin, Stirner, Mariana Cota, Liu, Yan, Kilavuz, Nurgul, Sacchi, Mariana, Thieblemont, Catherine
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Oral Abstract: ABCL-500 Longer Follow-Up Reaffirms Subcutaneous Epcoritamab Induces Deep and Durable Complete Remissions in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Updated Results From the Pivotal EPCORE NHL-1 Trial
Karimi, Yasmin, Ghesquieres, Herve, Jurczak, Wojciech, Cheah, Chan Y., Clausen, Michael Roost, Lugtenburg, Pieternella, Cunningham, David, Do, Young Rok, Lewis, David John, Gasiorowski, Robin, Kim, Tae Min, van der Poel, Marjolein, Poon, Michelle Limei, Feldman, Tatyana, Linton, Kim M., Sureda, Anna, Hutchings, Martin, Stirner, Mariana Cota, Liu, Yan, Kilavuz, Nurgul, Sacchi, Mariana, Thieblemont, Catherine
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
Thieblemont, Catherine, Phillips, Tycel, Ghesquieres, Herve, Cheah, Chan Y., Clausen, Michael Roost, Cunningham, David, Do, Young Rok, Feldman, Tatyana, Gasiorowski, Robin, Jurczak, Wojciech, Kim, Tae Min, Lewis, David John, van der Poel, Marjolein, Poon, Michelle Limei, Doerr, Thomas, Kilavuz, Nurgul, Chen, Menghui, Sacchi, Mariana, Elliott, Brian, Hutchings, Martin, Lugtenburg, Pieternella
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
Poster: ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
Thieblemont, Catherine, Phillips, Tycel, Ghesquieres, Herve, Cheah, Chan Y., Clausen, Michael Roost, Cunningham, David, Do, Young Rok, Feldman, Tatyana, Gasiorowski, Robin, Jurczak, Wojciech, Kim, Tae Min, Lewis, David John, van der Poel, Marjolein, Poon, Michelle Limei, Doerr, Thomas, Kilavuz, Nurgul, Chen, Menghui, Sacchi, Mariana, Elliott, Brian, Hutchings, Martin, Lugtenburg, Pieternella
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
AUGMENT: A phase 3, randomized trial to compare efficacy and safety of lenalidomide plus rituximab versus placebo plus rituximab in patients with relapsed/refractory indolent non-Hodgkin lymphoma (NHL)
Leonard, John, Gribben, John G., Trneny, Marek, Scheinberg, Phillip, Kilavuz, Nurgul, Patturajan, Meera, Fustier, Pierre
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
AUGMENT: A randomized, phase 3 trial in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) to compare efficacy and safety of lenalidomide plus rituximab (R 2 ) versus placebo plus rituximab
Leonard, John, Gribben, John G., Trněný, Marek, Scheinberg, Phillip, Tobinai, Kensei, Fowler, Nathan Hale, Kilavuz, Nurgul, Fustier, Pierre, Amoroso, Barbara
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Phase I/II study of durvalumab (anti–PD-L1 antibody) as monotherapy and in combination in patients with lymphoma or chronic lymphocytic leukemia
Witzig, Thomas E., Casulo, Carla, Cartron, Guillaume, Ruan, Jia, Rule, Simon, Ando, Kiyoshi, Burton, Cathy, Pinto, Antonio, Le Gouill, Steven, Fowler, Nathan Hale, Zinzani, Pier Luigi, De Bedout, Sabine, Kilavuz, Nurgul, Rettby, Nils, Czuczman, Myron Stefan, Santoro, Armando
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
BCMA-지시된 키메라 항원 수용체 T 세포 조성물 및 이의 방법 및 용도
WESTOBY MATTHEW, CASPARY ROBERT GUY, KUGLER DAVID G, BASHOUR KEENAN, KOEGEL ASHLEY, GERMEROTH LOTHAR, CHAN CALVIN, VARUN DIVYA, STEMBERGER CHRISTIAN, KILAVUZ NURGUL, HEGE KRISTEN, WU KAIDA, BRIGGS ADRIAN WRANGHAM, SALMON RUTH AMANDA, BATUREVYCH OLEKSANDR, BURGESS MICHAEL, POLTORAK MATEUSZ PAWEL
Year of Publication 15.11.2022
Get full text
Year of Publication 15.11.2022
Patent
CD19-지시된 키메라 항원 수용체 T 세포 조성물 및 이의 방법 및 용도
WESTOBY MATTHEW, CASPARY ROBERT GUY, KUGLER DAVID G, BASHOUR KEENAN, GERMEROTH LOTHAR, CHAN CALVIN, VARUN DIVYA, STEMBERGER CHRISTIAN, KILAVUZ NURGUL, HEGE KRISTEN, WU KAIDA, BRIGGS ADRIAN WRANGHAM, SALMON RUTH AMANDA, BATUREVYCH OLEKSANDR, BURGESS MICHAEL, POLTORAK MATEUSZ PAWEL
Year of Publication 15.11.2022
Get full text
Year of Publication 15.11.2022
Patent
Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
Nowakowski, Grzegorz S, Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S, Patel, Krish, Jäger, Ulrich, Manges, Robert F, Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell'Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier
Published in International journal of hematology (01.02.2022)
Get full text
Published in International journal of hematology (01.02.2022)
Journal Article
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
CHIU, Christopher W. L, KILAVUZ, Nurgul, ELLIOTT, Brian, SACCHI, Mariana
Year of Publication 19.10.2023
Get full text
Year of Publication 19.10.2023
Patent